Now showing items 1-10 of 88
Pharmacological treatment compliance and a description of its associated factors in patients with myasthenia gravis
(Revista de Neurología, 2018)
Introduction. Medication adherence is a public health problem and this has not been previously studied in myasthenia gravis patients Aim. To determine if patients with myasthenia gravis are adherent to treatment and ...
Thymectomy in nonthymomatous myasthenia gravis - Systematic review and meta-analysis
Background: The objective of this study is to evaluate by means of a systematic review, the efficacy of thymectomy as compared to medical treatment for non-thymomatous myasthenia gravis (MG). Methods: Medline, Embase, and ...
Clinical and epidemiological features of myasthenia gravis in Chilean population
(Blackwell Publishing Ltd, 2018)
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Objective: To provide an estimated prevalence and describe the clinical features of myasthenia gravis (MG) in Chile. Method: We carried out (i) a prevalence ...
Demyelinating disease in patients with myasthenia gravis
(Academia Brasileira de Neurologia - ABNEURO, 2008-03-01)
Myasthenia gravis (MG) is an autoimmune disease characterized by fluctuating muscle weakness, caused by impaired neuromuscular transmission. Patients with MG can present other autoimmune diseases in association, commonly ...
Rare Association Of Celiac Disease With Myasthenia Gravis In A Patient With Other Immune Disorders: A Case Report
(Aran Ediciones ASMadrid, 2016)
Myasthenia gravis and its association with lymphoproliferative disorders: A case series Miastenia gravis y su asociación con trastornos linfoproliferativos: Casos clínicos
(Sociedad Medica de Santiago, 2017)
© 2017, Sociedad Medica de Santiago. All rights reserved. Myasthenia gravis (MG) is a rare autoimmune disease of the neuromuscu-lar junction. It is characterized by variable weakness and excessive fatigability of skeletal ...